Propranolol (PROP), an adrenergic receptor antagonist, could prevent isoproterenol-induced polycystic ovary, enhancing the ovulation rate and reducing tyrosine hydroxylase and dopamine β-hydroxylase concentrations in the ovarian tissue [97, 98]. Here, TH is linked to polycystic ovary syndrome.